Clinical trial / 2001
Quercetin absorption in humans depended primarily on its sugar moiety rather than the food matrix, with glucosides absorbed faster and to a greater extent.
In a 4-way crossover study, 12 healthy volunteers received an onion supplement, quercetin-4'-O-glucoside (each equivalent to 100 mg quercetin), quercetin-3-O-rutinoside, and buckwheat tea (each equivalent to 200 mg quercetin). Only quercetin glucuronides, not free quercetin, were detected in plasma. Bioavailability was similar between onion supplement and quercetin-4'-O-glucoside (peak plasma levels 2.3 +/- 1.5 microg/mL at 0.7 +/- 0.2 h vs. 2.1 +/- 1.6 microg/mL at 0.7 +/- 0.3 h). Despite a higher dose, buckwheat tea and rutin achieved lower peak levels (0.6 +/- 0.7 microg/mL at 4.3 +/- 1.8 h vs. 0.3 +/- 0.3 microg/mL at 7.0 +/- 2.9 h), with terminal elimination half-life around 11 hours for all treatments.
- Study type
- Randomized four-way crossover trial
- Who was studied
- 12 healthy volunteers
- What was measured
- Quercetin bioavailability and pharmacokinetic parameters (peak plasma levels, time to peak, half-life)
THE PAPER
Pharmacokinetics and bioavailability of quercetin glycosides in humans.
Graefe EU, Wittig J, Mueller S, Riethling AK, Uehleke B, Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M. J Clin Pharmacol, 2001.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.